INS and cystic fibrosis: Although this is the rule when metabolic deterioration is evident, in the early stages of CFRD, when there is a minor metabolic deterioration and the nutritional status is not usually compromised, insulin therapy can represent a burden for people with CF, including by carrying the risk of hypoglycaemia, having higher costs, causing more stress, and requiring more education for its correct use.